SeaStar Medical Holding Corporation (NASDAQ:ICU) Short Interest Update

SeaStar Medical Holding Corporation (NASDAQ:ICU) was the recipient of a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 138,925 shares, an increase of 69.6% from the June 30th total of 81,907 shares. Based on an average daily trading volume, of 149,755 shares, the short-interest ratio is currently 0.9 days. Currently, 3.5% of the company’s stock are short sold.

SeaStar Medical Price Performance

Shares of ICU opened at $3.13 on Friday. SeaStar Medical has a 1-year low of $2.07 and a 1-year high of $12.50. The stock has a market cap of $12.52 million, a PE ratio of -0.65 and a beta of -1.05. The firm has a fifty day moving average price of $3.70 and a 200 day moving average price of $3.36.

SeaStar Medical (NASDAQ:ICU) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.90) earnings per share for the quarter, missing the consensus estimate of ($0.82) by ($0.08). The firm had revenue of $0.49 million during the quarter, compared to analyst estimates of $0.44 million. SeaStar Medical had a negative net margin of 828.62% and a negative return on equity of 146.29%. As a group, equities analysts expect that SeaStar Medical will post -3.58 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on ICU. Maxim Group set a $8.00 price target on SeaStar Medical and gave the stock a “buy” rating in a report on Thursday, May 14th. Weiss Ratings reissued a “sell (e+)” rating on shares of SeaStar Medical in a research report on Friday, July 17th. Finally, Wall Street Zen cut SeaStar Medical from a “hold” rating to a “sell” rating in a research note on Saturday, May 16th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, SeaStar Medical currently has a consensus rating of “Hold” and a consensus target price of $8.00.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in ICU. XTX Topco Ltd boosted its position in shares of SeaStar Medical by 395.4% during the 2nd quarter. XTX Topco Ltd now owns 60,983 shares of the company’s stock worth $26,000 after purchasing an additional 48,674 shares in the last quarter. Millennium Management LLC purchased a new position in shares of SeaStar Medical in the 3rd quarter valued at about $102,000. Finally, Jane Street Group LLC acquired a new stake in shares of SeaStar Medical in the fourth quarter valued at about $30,000. 1.69% of the stock is currently owned by institutional investors and hedge funds.

SeaStar Medical Company Profile

SeaStar Medical, Inc (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR.